| Name | 3-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]benzoic acid |
|---|---|
| Synonyms |
3-[(1-{[(1,1-dimethylethyl)oxy]carbonyl}-4-piperidinyl)methyl]benzoic acid
3-[(1-Boc-4-piperidinyl)methyl]benzoic acid 3-[(1-{[(1,1-dimethyIethyl)oxy]carbonyl}-4-piperidinyl)methyl]benzoic acid 3-((1-(tert-Butoxycarbonyl)piperidin-4-yl)methyl)benzoic acid |
| Molecular Formula | C18H25NO4 |
|---|---|
| Molecular Weight | 319.39500 |
| Exact Mass | 319.17800 |
| PSA | 66.84000 |
| LogP | 3.51230 |
| HS Code | 2933399090 |
|---|
|
~%
799283-53-7 |
| Literature: AVENTIS PHARMACEUTICALS INC. Patent: WO2004/100946 A1, 2004 ; Location in patent: Page 54 ; WO 2004/100946 A1 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |